TABLE 1.
Worldwide serogroup distribution of NTS isolated from humans
| Region | Country | % of isolates belonging to serogroup (epitope[s]): |
Yr(s) covered | Source or reference | |||
|---|---|---|---|---|---|---|---|
| B (O:4) | C (O:7, O:8) | D (O:9) | Other | ||||
| Africa | 30.9 | 19.5 | 44.6 | 5 | 2014 | WHO GFN | |
| Ethiopia | 16.9 | 28.6 | 47.9a | 3 | 1982–2012 | 19 | |
| Kenya | 57.5 | 9.3 | 33.2 | 0 | 2002–2004 | 20 | |
| Tunisia | 10.8 | 45.7 | 24.1 | 14.4 | 1994–2004 | 21 | |
| Asia | 26.2 | 27.3 | 45.4 | 1.1 | 2009 | WHO GFN | |
| Taiwan | 39 | 23 | 29 | 9 | 2004–2012 | 22 | |
| China | 56.9 | 6.0 | 14.6 | 21.0 | 2007–2012 | 23 | |
| Middle East | Saudi Arabia | 19.6 | 33.5 | 34.2 | 12.6 | 2008–2011 | 24 |
| Europe | 32.7 | 8.4 | 42 | 16.9 | 2012 | 26 | |
| North America | United States | 20.5 | 25.7 | 16.5 | 17.8 | 2012 | 25 |
a
Reported data include information for S. Typhi as well as NTS isolates.